Grazoprevir (MK-5172)/Elbasvir (MK-8742) Versus Boceprevir/Pegylated Interferon/Ribavarin for Chronic Hepatitis C Infection (MK-5172-066)

NCT02204475 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: Grazoprevir/Elbasvir
DRUG: Boceprevir
DRUG: PegIntron
DRUG: Ribavarin

Sponsor

Merck Sharp & Dohme LLC